The booming Adeno-Associated Virus (AAV) CDMO market is projected to reach $0.57B in 2025, with a CAGR of 20.86% through 2033. Driven by cell & gene therapy and vaccine development, key players are expanding capacity to meet surging demand. Explore market trends, regional analysis, and leading companies in this comprehensive report.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.